Login to Your Account

Combination Therapies the Way Forward

Newcomers Looking for Slice of Expanding AMD Market

By Peter Winter

Monday, July 22, 2013

In this second part of our focus on ocular diseases, we look at the latest developments taking place in the treatment of central vision disorders such as age-related macular degeneration (AMD). This disease, along with cataracts, diabetic retinopathy, and glaucoma, represents a considerable economic burden to the health systems of developed and developing countries . . . and the situation is predicted to get worse.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription